Risk Management's Impact on QMS - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

Risk Management's Impact on QMS

Risk Management is everywhere, and is not some lofty strategic element that is limited to top floor suits making enterprise-wide decisions. Risk is just another tool in the quiver of the compliance process; it is a method for streamlining your business, like any other compliance process.

Risk Management is becoming an integral part of the compliance process. Like anything else, Risk Management is simply a process. It’s a means of looking at potential hazards, assigning a weight to those hazards, and taking steps to control those hazards. There are many ways to look at Risk, and each industry has developed different risk based tools to suit their specific business needs. Get a glimpse at how compliance industries are utilizing risk as a core benchmarking metric for decision-making in the enterprise. Download White Paper Now.

Web: www.etq.com
Contact: info@etq.com

EtQ is the leading Quality, EHS, and Operational Risk and Compliance management software provider for identifying, mitigating and preventing high-risk events through integration, automation and collaboration. EtQ is headquartered in Farmingdale, NY, with main offices located in EMEA, the UK, and Arizona.

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
FindPharma Custom Search

Click here